These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 25284033)

  • 1. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
    Montouris GD; Wheless JW; Glauser TA
    Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
    Montouris G; Aboumatar S; Burdette D; Kothare S; Kuzniecky R; Rosenfeld W; Chung S
    Epilepsy Behav; 2020 Sep; 110():107146. PubMed ID: 32563898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological management of Lennox-Gastaut syndrome and critical literature review.
    Verrotti A; Striano P; Iapadre G; Zagaroli L; Bonanni P; Coppola G; Elia M; Mecarelli O; Franzoni E; Liso P; Vigevano F; Curatolo P
    Seizure; 2018 Dec; 63():17-25. PubMed ID: 30391662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ; Chin RFM
    Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
    Sankar R; Chez M; Pina-Garza JE; Dixon-Salazar T; Flamini JR; Hyslop A; McGoldrick P; Millichap JJ; Resnick T; Rho JM; Wolf S
    Seizure; 2023 Aug; 110():42-57. PubMed ID: 37321047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2014 Nov; 108(9):1627-36. PubMed ID: 25219353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rufinamide for the treatment of Lennox-Gastaut syndrome.
    Besag FM
    Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of clobazam tablets and film (AQST-120) for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ
    Expert Opin Pharmacother; 2019 Sep; 20(13):1563-1574. PubMed ID: 31373526
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.
    Strzelczyk A; Schubert-Bast S
    CNS Drugs; 2021 Jan; 35(1):61-83. PubMed ID: 33479851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Lennox-Gastaut syndrome beyond childhood: A comprehensive review.
    Samanta D
    Epilepsy Behav; 2021 Jan; 114(Pt A):107612. PubMed ID: 33243685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
    Cramer JA; Sapin C; François C
    Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial.
    Ohtsuka Y; Yoshinaga H; Shirasaka Y; Takayama R; Takano H; Iyoda K
    Epilepsy Res; 2016 Mar; 121():1-7. PubMed ID: 26827266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
    Sharawat IK; Panda PK; Panda P; Dawman L
    Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short-term efficacy and safety of rufinamide for Lennox-Gastaut syndrome].
    Takayama R; Fukumura S; Minagawa K; Watanabe T
    No To Hattatsu; 2016 Sep; 48(5):322-6. PubMed ID: 30010275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lennox-Gastaut syndrome. Management update.
    Al-Banji MH; Zahr DK; Jan MM
    Neurosciences (Riyadh); 2015 Jul; 20(3):207-12. PubMed ID: 26166587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Lennox-Gastaut Syndrome (LGS).
    Ferrie CD; Patel A
    Eur J Paediatr Neurol; 2009 Nov; 13(6):493-504. PubMed ID: 19211283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lennox-Gastaut syndrome: a comprehensive review.
    Asadi-Pooya AA
    Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lennox-Gastaut syndrome: an updateon treatment.
    Carmant L; Whiting S
    Can J Neurol Sci; 2012 Nov; 39(6):702-11. PubMed ID: 23227575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulthiame add-on therapy in children with Lennox-Gastaut syndrome: A study of 44 patients.
    Caraballo RH; Flesler S; Reyes Valenzuela G; Fortini S; Chacón S; Ross L; Noli D
    Seizure; 2018 Nov; 62():55-58. PubMed ID: 30286409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.